Liberate Medical develops a non-invasive respiratory muscle stimulator called VentFree for patients on mechanical ventilation. The device contracts expiratory muscles during mechanical ventilation to keep them active, potentially reducing atrophy and the duration of mechanical ventilation.

Liberate Medical

Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders.

Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support.  VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation.  

Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider. 

Keyhorse Capital (KSTC)

MedTech Innovator

National Science Foundation

The Vogt Awards

Newchip Accelerator

XLerateHealth

🚀 Exciting News from Liberate Medical! 🚀

We're thrilled to announce the launch of the PREVENT trial - a pivotal clinical trial that aims to demonstrate that our VentFree® Respiratory Muscle Stimulator reduces duration of invasive mechanical ventilation in patients at risk of being difficult to wean. 

🙏 Thank you and congratulations to everyone who has contributed to the successful launch of this important study. A special mention goes to The Prince of Wales Hospital, Baylor College of Medicine, and Providence Regional Medical Center Everett - Colby Campus who were the first sites to enroll patients worldwide! 

🌍 The PREVENT study aims to enroll 272 patients from up to 25 sites across the US, Australia and the EU and was made possible with a significant $6.5M grant from the US Department of Defense. 

🔗 Read the full press release here: https://lnkd.in/gMRYuwbK

Our co-founder and CEO, Angus M. was recently a guest on the Medsider podcast with host Scott Nelson 🎙️. Have a listen if you would like to learn more about our founding story, approach to product development and our upcoming pivotal trial.

Full details of the PREVENT study will be announced soon!

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Aug 7, 2024 5:18 PM	855cd826
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 7, 2024 5:18 PM	dad0a24a
translate crunchbase fundingrounds	general
peers	general	Aug 7, 2024 5:18 PM	ace4ae58
news basic	general	Aug 7, 2024 5:18 PM	82228414
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:LIBERATEMEDICAL

Liberate Medical